Bank of New York Mellon Corp logo BNY - Bank of New York Mellon Corp

Price: -- -- | CONSENSUS: Hold DETAILS
STRONG
BUY
0
BUY 10
HOLD 12
SELL 0
STRONG
SELL
0
| PRICE TARGET: $166.00 DETAILS
HIGH: $180.00
LOW: $147.00
MEDIAN: $168.00
CONSENSUS: $166.00
UPSIDE: 12.79%
AlphaVal

AlphaVal

Deterministic, archetype-aware fair value

Banks, Insurers & Asset Managers 85% confidence

Primary model: P/Tangible Book × ROE Quality

Valuation Signal Overvalued Moderate
Trading 34.7% above fair value
Current Price $147.18
Bear Case $76.02 48.3% downside ($76.02 - $147.18) / $147.18 = -48.3% ROTCE 16.8% → 2.11x TBV
Fair Value $109.26 25.8% downside ($109.26 - $147.18) / $147.18 = -25.8% ROTCE 22.4% → 3.03x TBV
Bull Case $129.20 12.2% downside ($129.20 - $147.18) / $147.18 = -12.2% ROTCE 25.8% → 3.59x TBV

Adjust Assumptions

22.4%
10.1%

Key Value Driver

ROTCE (22.4%) vs. cost of equity (10.1%)

Implied Market Multiple 4.09x

Plain-Language Summary

With ROTCE of 22.4% vs. 10.1% cost of equity, fair P/TBV is 3.03x on $36.02 tangible book, implying $109.26 per share. DDM cross-check: $30.63.

Analyst Consensus (External Reference)

Never blended into the bear/base/bull estimates above -- shown only as an outside comparison.

Average Target (22 analysts) $166.00
Analyst Range $147.00 – $180.00
Divergence from AlphaVal 34%

Warnings

⚠ Traditional cash flow models don't work well for banks — lending activity distorts how much cash the business actually generates.
⚠ Common valuation shortcuts don't apply here — for banks, interest payments are a core business cost, not overhead.
ℹ Dividend-based valuation: $30.63 (72% below our primary estimate). Large gaps suggest the dividend may not fully reflect the company's value.
ℹ Wall Street's average price target is $166.00 (from 22 analysts). Our estimate is 34% below the consensus -- consider that gap carefully.

Key Risks

  • Book value quality matters as much as level — check loan loss reserves
  • Interest rate sensitivity creates non-linear earnings surprises
  • Insurance reserving is actuarial, not financial — errors emerge slowly